Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer

The prediction of the response to Bacillus Calmette-Guerin (BCG) can help identify non-muscle-invasive bladder cancer (NMIBC) patients that may be better served with alternative therapy. Several cytokine profiles present promising results, but they are difficult to use in clinical practice. In this...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Zhong, Wenlong, Wang, Bo, Yu, Hao, Lin, Jianxun, Xia, Kun, Hou, Weibin, Yang, Meihua, Chen, Junyu, Yang, Meng, Wang, Xiaofei, Huang, Jian, Lin, Tianxin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458591/
https://ncbi.nlm.nih.gov/pubmed/32923138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1776060
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak